Tag: CRNX

Crinetics Pharmaceuticals, Inc. has unveiled encouraging top-line findings from its Phase 2 trial of paltusotine, an oral compound designed to ...

Crinetics Pharmaceuticals has recently made headlines with their successful $350 million private placement, which saw the sale of 8,333,334 shares ...

Crinetics Pharmaceuticals has recently made headlines with their successful private placement of 8,333,334 shares of common stock at $42.00 per ...